Moderna’s UK Expansion Fails to Impress as Shares Decline
Published on 09/26/2025 at 15:45 | Redaktion boerse-global.de
Moderna shares experienced a notable downturn this week, declining nearly 5% on Thursday to close at approximately €21. This sell-off occurred despite the company’s official unveiling of a major new research and manufacturing facility in Oxfordshire, UK. The market’s reaction highlights investor concerns that overshadow the positive announcement of a significant long-term investment.
The newly inaugurated Moderna Innovation and Technology Centre (MITC) represents a cornerstone of the company’s ten-year partnership with the British government. Moderna has committed over £1 billion to this venture, which will focus on research and development. The state-of-the-art facility boasts an annual production capacity of up to 100 million mRNA vaccine doses, a figure that can be scaled to 250 million during a pandemic. The project is expected to... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
